Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data
science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rare, monogenic diseases; and 33 additional programs in various stages of preclinical development. Recursion Pharmaceuticals, Inc. has strategic agreements with Bayer; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. The company was founded in 2013 and is based in Salt Lake City, Utah. The company trades on NMS exchange. The company headquarter is located in Salt Lake City ,United States.
| Ticker | RXRX |
| Long Name | Recursion Pharmaceuticals, Inc. |
| Short Name | Recursion Pharmaceuticals, Inc. |